| TLY |
Totally
|
AIM |
|
– |
0.24 |
-1.90% |
| POLX |
Polarean Imaging
|
AIM |
|
– |
0.08 |
-3.20% |
| PYC |
Physiomics
|
AIM |
|
£1.41M |
0.62 |
-3.80% |
| TRLS |
Trellus Health
|
AIM |
|
£1.53M |
0.95 |
7.30% |
| GUN |
Gunsynd
|
AIM |
|
£1.74M |
0.13 |
9.50% |
| VAL |
ValiRx
|
AIM |
|
£2.6M |
0.36 |
-2.20% |
| BELL |
Belluscura
|
AIM |
|
£3.01M |
0.75 |
-1.10% |
| GENI |
Genincode
|
AIM |
|
£3.65M |
1.17 |
1.40% |
| SUN |
Surgical Innovations Group
|
AIM |
|
£4.2M |
0.50 |
-2.30% |
| MHC |
MyHealthChecked
|
AIM |
|
£4.55M |
8.75 |
5.30% |
| TRX |
Tissue Regenix Group
|
AIM |
|
£5.16M |
7.25 |
-1.50% |
| PRM |
Proteome Sciences
|
AIM |
|
£6.45M |
1.86 |
8.00% |
| OPTI |
OptiBiotix Health
|
AIM |
|
£7.49M |
7.50 |
-3.30% |
| FUM |
Futura Medical
|
AIM |
|
£7.67M |
1.33 |
14.60% |
| AGL |
Angle
|
AIM |
|
£7.72M |
2.40 |
-0.70% |
| RUA |
RUA Life Sciences
|
AIM |
|
£9M |
14.87 |
-6.90% |
| CEL |
Celadon Pharmaceuticals
|
AIM |
|
£9.23M |
13.40 |
% |
| IXI |
Ixico
|
AIM |
|
£10.43M |
10.25 |
-1.50% |
| VRCI |
Verici Dx
|
AIM |
|
£10.97M |
0.70 |
-4.80% |
| GDR |
Genedrive
|
AIM |
|
£11.07M |
1.05 |
-1.60% |
| OBD |
Oxford BioDynamics
|
AIM |
|
£11.8M |
0.25 |
-4.00% |
| IHC |
Inspiration Healthcare Group
|
AIM |
|
£13.9M |
15.50 |
0.60% |
| COG |
Cambridge Cognition Holdings
|
AIM |
|
£15.07M |
37.00 |
-0.40% |
| FAB |
Fusion Antibodies
|
AIM |
|
£16.88M |
14.50 |
25.90% |
| EDEN |
Eden Research
|
AIM |
|
£20.8M |
4.00 |
-2.40% |
| SAR |
Sareum Holdings
|
AIM |
|
£24.16M |
17.50 |
-5.60% |
| NCYT |
Novacyt SA
|
AIM |
|
£25.03M |
35.32 |
4.20% |
| ABDX |
Abingdon Health
|
AIM |
|
£26M |
6.12 |
2.60% |
| AREC |
Arecor Therapeutics
|
AIM |
|
£30.77M |
85.00 |
-1.30% |
| POLB |
Poolbeg Pharma
|
AIM |
|
£31.02M |
4.29 |
-2.10% |
| IMM |
ImmuPharma
|
AIM |
|
£31.97M |
6.90 |
-3.00% |
| OHGR |
One Health Group
|
AIM |
0.02 |
£32.92M |
238.00 |
% |
| OBI |
Ondine Biomedical Inc
|
AIM |
|
£37.76M |
8.65 |
2.60% |
| HVO |
Hvivo
|
AIM |
3.33 |
£40.82M |
6.00 |
-5.10% |
| SBTX |
SkinBioTherapeutics
|
AIM |
|
£53.08M |
20.50 |
-14.90% |
| CREO |
Creo Medical Group
|
AIM |
|
£57.86M |
14.25 |
-0.80% |
| ANIC |
Agronomics
|
AIM |
|
£63.39M |
6.10 |
-0.60% |
| SPEC |
Inspecs Group
|
AIM |
|
£70.15M |
69.00 |
-0.30% |
| KMK |
Kromek Group
|
AIM |
|
£72.06M |
10.40 |
8.70% |
| EAH |
Eco Animal Health Group
|
AIM |
|
£76.23M |
111.00 |
-4.30% |
| SDI |
SDI Group
|
AIM |
|
£85.73M |
82.00 |
-1.50% |
| 4BB |
4basebio
|
AIM |
|
£89M |
575.00 |
-0.40% |
| BVXP |
Bioventix
|
AIM |
8.11 |
£96.66M |
1,800.50 |
-2.20% |
| EKF |
EKF Diagnostics Holdings
|
AIM |
|
£106.41M |
23.80 |
1.00% |
| ANP |
Anpario
|
Main Market |
2.15 |
£111.22M |
530.00 |
-0.90% |
| STX |
Shield Therapeutics
|
AIM |
|
£114.79M |
10.54 |
-7.90% |
| BMK |
Benchmark Holdings
|
AIM |
|
£135.69M |
22.05 |
1.50% |
| SCLP |
Scancell Holdings
|
AIM |
|
£137.51M |
13.75 |
-1.10% |
| DXRX |
Diaceutics
|
AIM |
|
£144.35M |
170.50 |
-0.50% |
| MXCT |
Maxcyte Inc
|
AIM |
|
£161.75M |
147.69 |
-1.20% |
| FARN |
Faron Pharmaceuticals OY
|
AIM |
|
£195.29M |
170.00 |
1.10% |
| ANCR |
Animalcare Group
|
AIM |
1.84 |
£195.4M |
286.38 |
-2.60% |
| TSTL |
Tristel
|
Main Market |
3.38 |
£200.97M |
415.00 |
1.60% |
| AVCT |
Avacta Group
|
AIM |
|
£225.26M |
49.50 |
-7.00% |
| NIOX |
Niox Group
|
AIM |
1.86 |
£280.85M |
66.20 |
% |
| PRTC |
Puretech Health
|
FTSE Small Cap |
|
£319.99M |
135.60 |
2.42% |
| AMS |
Advanced Medical Solutions Group
|
AIM |
1.24 |
£464.96M |
216.50 |
3.10% |
| AGY |
Allergy Therapeutics
|
AIM |
|
£730.83M |
11.50 |
-2.50% |
| SPI |
Spire Healthcare Group
|
FTSE 250 |
1.13 |
£821.63M |
208.00 |
1.96% |
| UPR |
Uniphar
|
AIM |
0.01 |
£859.82M |
332.00 |
0.90% |
| OXB |
Oxford BioMedica
|
FTSE Small Cap |
|
£1B |
830.00 |
-0.12% |
| INDV |
Indivior
|
FTSE 250 |
|
£1.54B |
1,238.00 |
-3.10% |
| HCM |
Hutchmed China
|
AIM |
|
£1.89B |
216.00 |
4.80% |
| GNS |
Genus
|
FTSE 250 |
1.01 |
£2.1B |
2,965.00 |
-6.17% |
| HIK |
Hikma Pharmaceuticals
|
FTSE 100 |
4.00 |
£3.39B |
1,551.00 |
1.44% |
| CTEC |
ConvaTec Group
|
FTSE 100 |
2.19 |
£4.5B |
232.00 |
0.87% |
| SN. |
Smith & Nephew
|
FTSE 100 |
2.24 |
£10.55B |
1,250.50 |
0.68% |
| HLN |
Haleon
|
FTSE 100 |
1.79 |
£33.75B |
382.70 |
1.00% |
| GSK |
GSK
|
FTSE 100 |
3.25 |
£76.48B |
1,925.00 |
2.58% |
| AZN |
AstraZeneca
|
FTSE 100 |
1.80 |
£210.92B |
14,040.00 |
3.24% |